Dariusz Hiczkiewicz

Dariusz Hiczkiewicz

Auto-generated profile, based on publicly available information

Dariusz Hiczkiewicz

Department of Interventional Cardiology and Cardiac Surgery, University of Zielona Gora, Collegium Medicum, Zielona Gora, Poland, Poland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
AZAgnieszka Zembron-Lacny
Agnieszka Zembron-Lacny
ATAnna Tylutka
Anna Tylutka
EWEryk Wacka
Eryk Wacka
EWEdyta Wawrzyniak-Gramacka
Edyta Wawrzyniak-Gramacka
DHDariusz Hiczkiewicz
Dariusz Hiczkiewicz
MCMilosz Czuba
Milosz Czuba
Intermittent exposure to hypoxia (IHE) increases the production of reactive oxygen and nitrogen species as well as erythropoietin (EPO), which stimulates the adaptation to intense physical activity. However, several studies suggest a protective effect of moderate hypoxia in cardiovascular disease (CVD) events. The effects of intense physical activity with IHE on oxi‐inflammatory mediators and their interaction with conventional CVD risk factors were investigated. Blood samples were collected from elite athletes (control n = 6, IHE n = 6) during a 6‐day IHE cycle using hypoxicator GO2 altitude. IHE was held once a day, at least 2 hours after training. In serum, hydrogen peroxide (H2O2), nitric oxide (NO), 3‐nitrotyrosine (3‐Nitro), proinflammatory cytokines (IL‐1β and TNFα), high sensitivity C‐reactive protein (hsCRP), and heat shock protein 27 (HSP27) were determined by the commercial immunoenzyme (ELISA kits) or colorimetric methods. Serum erythropoietin (EPO) level was measured by ELISA kit every day of hypoxia. IHE was found to significantly increase H2O2, NO, and HSP27 but to decrease 3NT concentrations. The changes in 3NT and HSP27 following hypoxia proved to enhance NO bioavailability and endothelial function. In the present study, the oxi‐inflammatory mediators IL‐1β and hsCRP increased in IHE group but they did not exceed the reference values. The serum EPO level increased on the 3rd day of IHE, then decreased on 5th day of IHE, and correlated with NO/H2O2 ratio (rs = 0.640, P < 0.05). There were no changes in haematological markers contrary to lipoproteins such as low‐density lipoprotein (LDL) and non‐high‐density lipoprotein (non‐HDL) which showed a decreasing trend in response to hypoxic exposure. The study demonstrated that IHE combined with sports activity reduced a risk of endothelial dysfunction and atherogenesis in athletes even though the oxi‐inflammatory processes were enhanced. Therefore, 6‐day IHE seems to be a potential therapeutic and nonpharmacological method to reduce CVD risk, especially in elite athletes participating in strenuous training.

23 August 2025 in Archives of Medical Science
Verified
Journal Article
Open access
JBJan Budzianowski
Jan Budzianowski
DHDariusz Hiczkiewicz
Dariusz Hiczkiewicz
HFHubert Ficner
Hubert Ficner
JRJanusz Rzeźniczak
Janusz Rzeźniczak
MSMarek Słomczyński
Marek Słomczyński
PBPaweł Burchardt
Paweł Burchardt
At present hematological indices and biomarkers of inflammation that may be associated with atherosclerosis and the prediction of acute coronary syndromes (ACS) attract a lot of academic attention. This update focused review aims to provide an overview of selected ACS biomarkers: white blood cells, neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, Systemic Inflammatory Index (SII), Systemic Inflammatory Response Index (SIRI) and Lipoprotein (a). Novel inflammatory-lipid biomarkers such as hsCRP to high density lipoprotein cholesterol (HDL-C) ratio, Neutrophils to HDL-C ratio, and Monocyte to HDL-C ratio may improve ACS diagnosis, risk stratification, clinical prognosis and optimal management. These indices are inexpensive and easily obtained in daily clinical practice. Artificial intelligence and genetic analysis may improve their diagnostic performance and guide clinical management. The recent data also emphasize that these indices may be a promising clinical tool for assessing ACS patients and monitoring the effectiveness of emerging anti-inflammatory strategies.